Heat Risks of Common Medications: How SSRIs, Antidepressants & Diabetes Drugs Affect You in Extreme Heat

Certain common medications, including Selective Serotonin Reuptake Inhibitors (SSRIs) and diabetes treatments, can increase a person’s risk of heat-related illness or lose effectiveness during extreme heat, according to pharmacist warnings and health advisories reported by KCCI and the MHRA. These medications may interfere with the body’s ability to regulate temperature or degrade when exposed to high heat.

Pharmacists and health officials have identified a specific risk for patients taking antidepressants, particularly SSRIs, during heat waves. According to reporting from WAFB and ABC11 News, these medications can affect the body’s thermoregulation, potentially making it harder for the body to cool itself through sweating.

This physiological change increases the likelihood of heat exhaustion or heatstroke when temperatures rise. The reports emphasize that patients on these medications should take extra precautions to stay hydrated and remain in cool environments.

How do SSRIs and antidepressants increase heat risk?

SSRIs alter the way the brain and body respond to temperature. According to WAFB, these antidepressants can disrupt the body’s natural cooling mechanisms. This impairment means a person may not realize they are overheating until they reach a critical state of heat illness.

ClickOnDetroit and WDIV Local 4 report that this increased vulnerability makes it essential for patients to monitor their symptoms more closely than those not taking these medications. The risk is not limited to a single drug but extends across the class of SSRIs commonly prescribed for depression and anxiety.

What happens to diabetes medication in extreme heat?

Extreme temperatures can compromise the chemical stability of essential medications. The Medicines and Healthcare products Regulatory Agency (MHRA) issued advice regarding the protection of diabetes medications, specifically insulin, during heat waves.

According to the EMJ, the MHRA warns that exposure to high temperatures can cause diabetes medications to break down. When the medication degrades, it may no longer provide the intended glucose-lowering effect, which can lead to unstable blood sugar levels for the patient.

The MHRA recommends that patients store these medications according to the specific temperature guidelines provided by the manufacturer and avoid leaving them in cars or direct sunlight.

How can patients protect themselves during heat waves?

Medical professionals and regulatory bodies suggest several specific steps to mitigate the risks associated with medication and heat. According to KCCI and the MHRA, patients should prioritize the following:

• Store medications in a cool, dry place away from direct sunlight to prevent chemical degradation.
• Increase fluid intake to compensate for potential disruptions in the body’s sweating and cooling processes.
• Limit outdoor activity during the hottest parts of the day.
• Consult a pharmacist or prescribing physician to understand if a specific medication increases individual susceptibility to heatstroke.

The MHRA specifically highlights that for insulin users, maintaining the cold chain is critical. If a medication is suspected of having been exposed to temperatures outside its recommended range, the MHRA suggests contacting a pharmacist to determine if the drug is still safe and effective to use.

While the reports from KCCI, ABC11, and WAFB focus on the immediate dangers of heat illness, they collectively frame the issue as a matter of medication interaction with environmental stress. The contrast between the two risks is clear: SSRIs affect the body’s internal response to heat, while heat affects the external stability of diabetes medications.